Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RELB
|
ENSG00000104856.9 | RELB proto-oncogene, NF-kB subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RELB | hg19_v2_chr19_+_45504688_45504782 | 0.19 | 2.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_159174701 | 3.00 |
ENST00000435307.1
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr15_+_33010175 | 2.79 |
ENST00000300177.4
ENST00000560677.1 ENST00000560830.1 |
GREM1
|
gremlin 1, DAN family BMP antagonist |
chr14_-_106967788 | 2.75 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr2_+_89952792 | 2.43 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr2_-_89476644 | 2.35 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
chr22_+_23222886 | 2.34 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr22_-_19512893 | 2.16 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr2_-_89619904 | 2.13 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr13_-_78492927 | 2.11 |
ENST00000334286.5
|
EDNRB
|
endothelin receptor type B |
chr19_+_42381173 | 2.10 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr13_-_78492955 | 2.10 |
ENST00000446573.1
|
EDNRB
|
endothelin receptor type B |
chr19_+_42381337 | 2.00 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr2_-_89310012 | 1.96 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr11_+_18287721 | 1.92 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr11_+_18287801 | 1.88 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr2_-_89247338 | 1.82 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr22_+_23134974 | 1.71 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr12_-_8815215 | 1.70 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr12_-_8815299 | 1.68 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr6_-_29527702 | 1.64 |
ENST00000377050.4
|
UBD
|
ubiquitin D |
chr22_+_22786288 | 1.64 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr2_-_89340242 | 1.56 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr2_-_89568263 | 1.54 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr19_-_6591113 | 1.50 |
ENST00000423145.3
ENST00000245903.3 |
CD70
|
CD70 molecule |
chr7_+_22766766 | 1.48 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr1_-_95392635 | 1.42 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr1_+_161228517 | 1.39 |
ENST00000504449.1
|
PCP4L1
|
Purkinje cell protein 4 like 1 |
chr1_+_11249398 | 1.33 |
ENST00000376819.3
|
ANGPTL7
|
angiopoietin-like 7 |
chr17_-_74547256 | 1.33 |
ENST00000589145.1
|
CYGB
|
cytoglobin |
chr1_-_186649543 | 1.32 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
chr2_+_114163945 | 1.31 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr14_-_106471723 | 1.30 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr19_+_18492973 | 1.25 |
ENST00000595973.2
|
GDF15
|
growth differentiation factor 15 |
chr7_+_89783689 | 1.21 |
ENST00000297205.2
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1 |
chr7_+_33945106 | 1.16 |
ENST00000426693.1
|
BMPER
|
BMP binding endothelial regulator |
chr12_-_8815404 | 1.16 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr3_-_168864315 | 1.14 |
ENST00000475754.1
ENST00000484519.1 |
MECOM
|
MDS1 and EVI1 complex locus |
chr17_+_12569306 | 1.13 |
ENST00000425538.1
|
MYOCD
|
myocardin |
chr1_+_201979645 | 1.13 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr4_-_74864386 | 1.07 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr13_+_53602894 | 1.06 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
chr10_-_118031778 | 1.04 |
ENST00000369236.1
|
GFRA1
|
GDNF family receptor alpha 1 |
chrX_-_133119895 | 1.03 |
ENST00000370818.3
|
GPC3
|
glypican 3 |
chr12_-_8815477 | 1.02 |
ENST00000433590.2
|
MFAP5
|
microfibrillar associated protein 5 |
chr4_-_74964904 | 1.02 |
ENST00000508487.2
|
CXCL2
|
chemokine (C-X-C motif) ligand 2 |
chr5_-_146833485 | 1.02 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr5_-_146833222 | 0.97 |
ENST00000534907.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chrX_-_65253506 | 0.97 |
ENST00000427538.1
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chr14_-_25045446 | 0.97 |
ENST00000216336.2
|
CTSG
|
cathepsin G |
chr2_-_36779411 | 0.95 |
ENST00000406220.1
|
AC007401.2
|
Uncharacterized protein |
chr12_+_54422142 | 0.91 |
ENST00000243108.4
|
HOXC6
|
homeobox C6 |
chr1_-_204436344 | 0.91 |
ENST00000367184.2
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
chr7_-_27239703 | 0.91 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
chr10_+_89419370 | 0.88 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr10_+_30722866 | 0.86 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr18_-_70535177 | 0.86 |
ENST00000327305.6
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1 |
chr2_-_27718052 | 0.85 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chrX_+_15518923 | 0.85 |
ENST00000348343.6
|
BMX
|
BMX non-receptor tyrosine kinase |
chr2_-_56150184 | 0.84 |
ENST00000394554.1
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr1_+_37940153 | 0.84 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr18_+_21529811 | 0.83 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
chr10_-_7708918 | 0.81 |
ENST00000256861.6
ENST00000397146.2 ENST00000446830.2 ENST00000397145.2 |
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
chr3_+_148415571 | 0.81 |
ENST00000497524.1
ENST00000349243.3 ENST00000542281.1 ENST00000418473.2 ENST00000404754.2 |
AGTR1
|
angiotensin II receptor, type 1 |
chr22_-_37640277 | 0.78 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr1_+_117297007 | 0.77 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr12_-_53074182 | 0.77 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
chr11_-_5271122 | 0.77 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
chr14_+_52734401 | 0.76 |
ENST00000306051.2
ENST00000553372.1 |
PTGDR
|
prostaglandin D2 receptor (DP) |
chr8_-_57472154 | 0.75 |
ENST00000499425.1
ENST00000523664.1 ENST00000518943.1 ENST00000524338.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
chr3_-_156878540 | 0.75 |
ENST00000461804.1
|
CCNL1
|
cyclin L1 |
chr7_-_22539771 | 0.75 |
ENST00000406890.2
ENST00000424363.1 |
STEAP1B
|
STEAP family member 1B |
chr22_-_28490123 | 0.74 |
ENST00000442232.1
|
TTC28
|
tetratricopeptide repeat domain 28 |
chr9_+_35792151 | 0.73 |
ENST00000342694.2
|
NPR2
|
natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
chr19_-_17958771 | 0.72 |
ENST00000534444.1
|
JAK3
|
Janus kinase 3 |
chr2_+_242498135 | 0.70 |
ENST00000318407.3
|
BOK
|
BCL2-related ovarian killer |
chr5_+_140588269 | 0.69 |
ENST00000541609.1
ENST00000239450.2 |
PCDHB12
|
protocadherin beta 12 |
chr9_+_72658490 | 0.69 |
ENST00000377182.4
|
MAMDC2
|
MAM domain containing 2 |
chr15_-_89438742 | 0.69 |
ENST00000562281.1
ENST00000562889.1 ENST00000359595.3 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
chr21_-_43373999 | 0.68 |
ENST00000380486.3
|
C2CD2
|
C2 calcium-dependent domain containing 2 |
chr12_+_50690489 | 0.68 |
ENST00000598429.1
|
AC140061.12
|
Uncharacterized protein |
chr18_-_53068940 | 0.68 |
ENST00000562638.1
|
TCF4
|
transcription factor 4 |
chr2_+_159825143 | 0.67 |
ENST00000454300.1
ENST00000263635.6 |
TANC1
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
chr9_+_101705893 | 0.67 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr16_-_2059748 | 0.67 |
ENST00000562103.1
ENST00000431526.1 |
ZNF598
|
zinc finger protein 598 |
chr1_-_6321035 | 0.65 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr9_+_33240157 | 0.65 |
ENST00000379721.3
|
SPINK4
|
serine peptidase inhibitor, Kazal type 4 |
chr17_-_46799872 | 0.65 |
ENST00000290294.3
|
PRAC1
|
prostate cancer susceptibility candidate 1 |
chr22_-_37640456 | 0.64 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr12_-_108991812 | 0.64 |
ENST00000392806.3
ENST00000547567.1 |
TMEM119
|
transmembrane protein 119 |
chr22_-_30642728 | 0.63 |
ENST00000403987.3
|
LIF
|
leukemia inhibitory factor |
chr19_-_17958832 | 0.62 |
ENST00000458235.1
|
JAK3
|
Janus kinase 3 |
chr16_+_85932760 | 0.62 |
ENST00000565552.1
|
IRF8
|
interferon regulatory factor 8 |
chr19_-_47128294 | 0.61 |
ENST00000596260.1
ENST00000597185.1 ENST00000598865.1 ENST00000594275.1 ENST00000291294.2 |
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP) |
chr8_+_38644715 | 0.61 |
ENST00000317827.4
ENST00000379931.3 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
chr20_+_30225682 | 0.60 |
ENST00000376075.3
|
COX4I2
|
cytochrome c oxidase subunit IV isoform 2 (lung) |
chr10_+_104154229 | 0.60 |
ENST00000428099.1
ENST00000369966.3 |
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr3_-_3152031 | 0.59 |
ENST00000383846.1
ENST00000427088.1 ENST00000446632.2 ENST00000438560.1 |
IL5RA
|
interleukin 5 receptor, alpha |
chr19_+_17638059 | 0.59 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
chr14_+_86401039 | 0.58 |
ENST00000557195.1
|
CTD-2341M24.1
|
CTD-2341M24.1 |
chr14_-_69446034 | 0.58 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr22_-_38380543 | 0.58 |
ENST00000396884.2
|
SOX10
|
SRY (sex determining region Y)-box 10 |
chr1_-_202130702 | 0.57 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr12_-_127256772 | 0.57 |
ENST00000536517.1
|
LINC00944
|
long intergenic non-protein coding RNA 944 |
chr6_+_138188351 | 0.57 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr5_-_111091948 | 0.57 |
ENST00000447165.2
|
NREP
|
neuronal regeneration related protein |
chrX_+_153059608 | 0.56 |
ENST00000370087.1
|
SSR4
|
signal sequence receptor, delta |
chr12_+_104324112 | 0.56 |
ENST00000299767.5
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1 |
chr12_-_92539614 | 0.56 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr1_+_110453514 | 0.56 |
ENST00000369802.3
ENST00000420111.2 |
CSF1
|
colony stimulating factor 1 (macrophage) |
chr11_+_75428857 | 0.56 |
ENST00000198801.5
|
MOGAT2
|
monoacylglycerol O-acyltransferase 2 |
chr19_+_17638041 | 0.56 |
ENST00000601861.1
|
FAM129C
|
family with sequence similarity 129, member C |
chr21_-_44898015 | 0.55 |
ENST00000332440.3
|
LINC00313
|
long intergenic non-protein coding RNA 313 |
chr18_-_53068782 | 0.55 |
ENST00000569012.1
|
TCF4
|
transcription factor 4 |
chr12_-_40013553 | 0.55 |
ENST00000308666.3
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2 |
chr18_-_71959159 | 0.55 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
chr2_+_219745020 | 0.54 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr4_-_114900126 | 0.54 |
ENST00000541197.1
|
ARSJ
|
arylsulfatase family, member J |
chr1_+_201979743 | 0.54 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr9_-_136344197 | 0.54 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr18_-_53068911 | 0.53 |
ENST00000537856.3
|
TCF4
|
transcription factor 4 |
chr3_+_52529346 | 0.53 |
ENST00000321725.6
|
STAB1
|
stabilin 1 |
chr12_-_54982420 | 0.52 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr4_-_74904398 | 0.52 |
ENST00000296026.4
|
CXCL3
|
chemokine (C-X-C motif) ligand 3 |
chr1_+_110453203 | 0.52 |
ENST00000357302.4
ENST00000344188.5 ENST00000329608.6 |
CSF1
|
colony stimulating factor 1 (macrophage) |
chr7_+_150498783 | 0.52 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
chr11_+_102188272 | 0.52 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr3_-_186262166 | 0.52 |
ENST00000307944.5
|
CRYGS
|
crystallin, gamma S |
chr5_-_150521192 | 0.52 |
ENST00000523714.1
ENST00000521749.1 |
ANXA6
|
annexin A6 |
chr17_-_40828969 | 0.51 |
ENST00000591022.1
ENST00000587627.1 ENST00000293349.6 |
PLEKHH3
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
chr9_-_130517522 | 0.51 |
ENST00000373274.3
ENST00000420366.1 |
SH2D3C
|
SH2 domain containing 3C |
chr1_+_110453462 | 0.50 |
ENST00000488198.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr1_-_202129105 | 0.50 |
ENST00000367279.4
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr19_-_38747172 | 0.50 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr10_+_124221036 | 0.50 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr12_-_49259643 | 0.50 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr3_-_156878482 | 0.50 |
ENST00000295925.4
|
CCNL1
|
cyclin L1 |
chrX_+_67913471 | 0.49 |
ENST00000374597.3
|
STARD8
|
StAR-related lipid transfer (START) domain containing 8 |
chr12_-_57443886 | 0.49 |
ENST00000300119.3
|
MYO1A
|
myosin IA |
chr6_+_138188551 | 0.49 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr16_+_57392684 | 0.48 |
ENST00000219235.4
|
CCL22
|
chemokine (C-C motif) ligand 22 |
chr8_-_65711310 | 0.48 |
ENST00000310193.3
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1 |
chr19_+_45504688 | 0.48 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
chr6_+_126221034 | 0.48 |
ENST00000433571.1
|
NCOA7
|
nuclear receptor coactivator 7 |
chr1_-_202129704 | 0.47 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr8_+_73449625 | 0.47 |
ENST00000523207.1
|
KCNB2
|
potassium voltage-gated channel, Shab-related subfamily, member 2 |
chrX_+_37208540 | 0.47 |
ENST00000466533.1
ENST00000542554.1 ENST00000543642.1 ENST00000484460.1 ENST00000449135.2 ENST00000463135.1 ENST00000465127.1 |
PRRG1
TM4SF2
|
proline rich Gla (G-carboxyglutamic acid) 1 Uncharacterized protein; cDNA FLJ59144, highly similar to Tetraspanin-7 |
chr4_-_185275104 | 0.47 |
ENST00000317596.3
|
RP11-290F5.2
|
RP11-290F5.2 |
chr4_+_74735102 | 0.47 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
chr8_+_72755796 | 0.46 |
ENST00000524152.1
|
RP11-383H13.1
|
Protein LOC100132891; cDNA FLJ53548 |
chr7_+_142423143 | 0.46 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
chr1_+_110453109 | 0.46 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr11_+_102188224 | 0.45 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chrX_-_73072534 | 0.45 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
chr1_+_95975672 | 0.44 |
ENST00000440116.2
ENST00000456933.1 |
RP11-286B14.1
|
RP11-286B14.1 |
chr12_+_6309517 | 0.43 |
ENST00000382519.4
ENST00000009180.4 |
CD9
|
CD9 molecule |
chr6_-_36355513 | 0.43 |
ENST00000340181.4
ENST00000373737.4 |
ETV7
|
ets variant 7 |
chr9_-_140335789 | 0.43 |
ENST00000344119.2
ENST00000371506.2 |
ENTPD8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr12_+_6308881 | 0.43 |
ENST00000382518.1
ENST00000536586.1 |
CD9
|
CD9 molecule |
chr1_-_113253977 | 0.42 |
ENST00000606505.1
ENST00000605933.1 |
RP11-426L16.10
|
Rho-related GTP-binding protein RhoC |
chr1_+_207669573 | 0.42 |
ENST00000400960.2
ENST00000534202.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
chrX_-_153599578 | 0.42 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr12_-_55378470 | 0.41 |
ENST00000524668.1
ENST00000533607.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr6_+_138188378 | 0.41 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr19_-_52005009 | 0.41 |
ENST00000291707.3
|
SIGLEC12
|
sialic acid binding Ig-like lectin 12 (gene/pseudogene) |
chr14_+_75988768 | 0.40 |
ENST00000286639.6
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr5_+_140579162 | 0.40 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
chrX_+_48644962 | 0.40 |
ENST00000376670.3
ENST00000376665.3 |
GATA1
|
GATA binding protein 1 (globin transcription factor 1) |
chr3_-_155461515 | 0.40 |
ENST00000399242.2
|
AC104472.1
|
CDNA FLJ26134 fis, clone TMS03713; Uncharacterized protein |
chr2_-_163099546 | 0.40 |
ENST00000447386.1
|
FAP
|
fibroblast activation protein, alpha |
chr7_+_150498610 | 0.39 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
chr17_-_40829026 | 0.39 |
ENST00000412503.1
|
PLEKHH3
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
chr1_-_1356719 | 0.39 |
ENST00000520296.1
|
ANKRD65
|
ankyrin repeat domain 65 |
chr19_+_496454 | 0.39 |
ENST00000346144.4
ENST00000215637.3 ENST00000382683.4 |
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1 |
chr16_-_67978016 | 0.39 |
ENST00000264005.5
|
LCAT
|
lecithin-cholesterol acyltransferase |
chr12_-_49318715 | 0.39 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
chr2_+_176957619 | 0.39 |
ENST00000392539.3
|
HOXD13
|
homeobox D13 |
chr16_-_2059797 | 0.39 |
ENST00000563630.1
|
ZNF598
|
zinc finger protein 598 |
chr19_+_14142535 | 0.38 |
ENST00000263379.2
|
IL27RA
|
interleukin 27 receptor, alpha |
chr11_-_58345569 | 0.37 |
ENST00000528954.1
ENST00000528489.1 |
LPXN
|
leupaxin |
chr4_-_48683188 | 0.37 |
ENST00000505759.1
|
FRYL
|
FRY-like |
chr12_+_56473628 | 0.36 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
chr1_+_207669613 | 0.36 |
ENST00000367049.4
ENST00000529814.1 |
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group) |
chr3_-_151176497 | 0.36 |
ENST00000282466.3
|
IGSF10
|
immunoglobulin superfamily, member 10 |
chr9_+_133259836 | 0.36 |
ENST00000455439.2
|
HMCN2
|
hemicentin 2 |
chr22_+_37318082 | 0.36 |
ENST00000406230.1
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
chr1_+_112939121 | 0.36 |
ENST00000441739.1
|
CTTNBP2NL
|
CTTNBP2 N-terminal like |
chr11_-_75062730 | 0.35 |
ENST00000420843.2
ENST00000360025.3 |
ARRB1
|
arrestin, beta 1 |
chr5_+_134181755 | 0.35 |
ENST00000504727.1
ENST00000435259.2 ENST00000508791.1 |
C5orf24
|
chromosome 5 open reading frame 24 |
chr8_-_95229531 | 0.35 |
ENST00000450165.2
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine) |
chr12_-_54982300 | 0.34 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr1_-_113249734 | 0.34 |
ENST00000484054.3
ENST00000369636.2 ENST00000369637.1 ENST00000285735.2 ENST00000369638.2 |
RHOC
|
ras homolog family member C |
chr9_+_127539481 | 0.34 |
ENST00000373580.3
|
OLFML2A
|
olfactomedin-like 2A |
chr10_+_102756800 | 0.34 |
ENST00000370223.3
|
LZTS2
|
leucine zipper, putative tumor suppressor 2 |
chr15_-_82824843 | 0.34 |
ENST00000560826.1
ENST00000559187.1 ENST00000330339.7 |
RPS17
|
ribosomal protein S17 |
chr11_-_75062829 | 0.33 |
ENST00000393505.4
|
ARRB1
|
arrestin, beta 1 |
chr4_+_39046615 | 0.33 |
ENST00000261425.3
ENST00000508137.2 |
KLHL5
|
kelch-like family member 5 |
chr8_+_101170563 | 0.33 |
ENST00000520508.1
ENST00000388798.2 |
SPAG1
|
sperm associated antigen 1 |
chrX_+_37208521 | 0.33 |
ENST00000378628.4
|
PRRG1
|
proline rich Gla (G-carboxyglutamic acid) 1 |
chr14_+_75988851 | 0.33 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr16_+_89686991 | 0.33 |
ENST00000393092.3
|
DPEP1
|
dipeptidase 1 (renal) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.9 | 2.8 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.5 | 1.5 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
0.4 | 1.3 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 2.0 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.4 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) response to prolactin(GO:1990637) |
0.3 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.8 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.3 | 1.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 0.8 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.2 | 2.0 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.2 | 0.6 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.2 | 1.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.2 | 1.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.2 | 0.6 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 2.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.5 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 0.6 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.1 | 1.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.6 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 0.7 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.1 | 4.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 1.0 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 6.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 1.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 17.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 1.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 1.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.9 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 3.7 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 1.0 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 1.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.4 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.2 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.1 | 0.8 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 2.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.5 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 1.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.9 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.3 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 1.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0043132 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) NAD transport(GO:0043132) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.0 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.0 | 0.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 3.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 8.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.0 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.0 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 1.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.3 | GO:1901727 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.0 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 5.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 4.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.4 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.9 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.5 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 0.9 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 9.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 2.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 1.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.8 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 2.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 1.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 3.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 5.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 1.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.3 | 0.9 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 2.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 0.8 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.3 | 1.3 | GO:0050473 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.3 | 0.8 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.3 | 1.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.3 | 2.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 2.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 3.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.2 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.1 | 0.3 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.1 | 1.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.9 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 24.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.9 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 3.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 1.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.0 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 5.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 1.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) metallodipeptidase activity(GO:0070573) |
0.0 | 0.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 1.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 2.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 1.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 3.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 5.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 5.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 2.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 3.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 2.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 7.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |